COVID-19 Patients Need to Be Tested for Bacteria and Fungi, Not Just the Coronavirus

In the midst of the global COVID-19 pandemic, hospitals are relying on tests capable of delivering reliable results, minimizing transmission risk and reducing time to treatment in the patients who need it most. Doctors are laser-focused on obtaining and using these tests to identify and treat patients with coronavirus. Yet the emerging risk of co-infections is pressuring hospitals to broaden their patient testing portfolios to address new mortality risks.

This is not a new problem, patients have long been at risk of getting infected by bacteria or fungi in the hospital environment. Hospitalized COVID-19 patients are at increased risk of getting these infections, often with deadly results.

An estimated one in seven COVID-19 patients will develop a secondary infection while hospitalized. Further, a separate study found that only about 50 percent of patient deaths were due to the original viral infection, while the other 50 percent were caused by subsequent secondary infections.